Cannell & Co. Silk Road Medical Inc Transaction History

Cannell & Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$28.03 - $45.8 $253,531 - $414,261	-9,045 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$44.0 - $65.8 $284,460 - $425,397	-6,465 Reduced 41.68%	9,045 $498,000
Q2 2021 Aug 09, 2021	SELL	$44.66 - $63.06 $2.62 Million - $3.7 Million	-58,705 Reduced 79.1%	15,510 $742,000
Q4 2020 Feb 11, 2021	SELL	$55.51 - $69.94 $2.83 Million - $3.57 Million	-51,000 Reduced 40.73%	74,215 $4.67 Million
Q3 2020 Nov 12, 2020	SELL	$42.19 - $69.61 $5.17 Million - $8.52 Million	-122,431 Reduced 49.44%	125,215 $8.42 Million
Q1 2020 May 05, 2020	SELL	$23.16 - $47.8 $1.23 Million - $2.53 Million	-53,000 Reduced 17.63%	247,646 $7.8 Million
Q4 2019 Feb 10, 2020	BUY	$27.97 - $40.38 $8.41 Million - $12.1 Million	300,646 New	300,646 $12.1 Million

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

Stay updated on Cannell & Co. with notifications on news.